Indegene’s valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton
Private equity firm Carlyle Group and Brighton Park Capital are investing $200 million in Indegene, the Bengaluru-headquartered
Read morePrivate equity firm Carlyle Group and Brighton Park Capital are investing $200 million in Indegene, the Bengaluru-headquartered
Read moreDr Reddy’s Laboratories on Saturday said it has inked a pact with Glenmark Pharmaceuticals to acquire its
Read moreIndian pharmaceutical company Laurus Labs Ltd. plans to spend as much as 15 billion rupees ($202 million)
Read more